Evaluation of antifungal effect and toxicity of xanthyletin and two bacterial metabolites against Thai isolates of Pythium insidiosum
Language English Country Great Britain, England Media electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
32161276
PubMed Central
PMC7066183
DOI
10.1038/s41598-020-61271-0
PII: 10.1038/s41598-020-61271-0
Knihovny.cz E-resources
- MeSH
- Antifungal Agents pharmacology MeSH
- Antiparasitic Agents pharmacology MeSH
- Bacteria chemistry metabolism MeSH
- Cell Line MeSH
- Fibroblasts drug effects MeSH
- Hyphae drug effects ultrastructure MeSH
- Complex Mixtures MeSH
- Coumarins pharmacology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Pythium drug effects MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antifungal Agents MeSH
- Antiparasitic Agents MeSH
- Complex Mixtures MeSH
- Coumarins MeSH
- xanthyletine MeSH Browser
Pythiosis is a harmful disease caused by Pythium insidiosum, an aquatic oomycete. Therapeutic protocols based on antifungal drugs are often ineffective because the cytoplasmic membrane of P. insidiosum does not contain ergosterol. Therefore, the treatment of pythiosis is still challenging, particularly making use of natural products and secondary metabolites from bacteria. In this study, xanthyletin and substances obtained from Pseudomonas stutzeri ST1302 and Klebsiella pneumoniae ST2501 exhibited anti-P. insidiosum activity and, moreover, xanthyletin was non-toxic against human cell lines. The hyphae of P. insidiosum treated with these three substances exhibited lysis holes on a rough surface and release of anamorphic material. Therefore, xanthyletin could be considered a promising alternative agent for treating cutaneous pythiosis in the near future.
See more in PubMed
Gaastra W, et al. Pythium insidiosum: an overview. Vet. Microbiol. 2010;146:1–16. doi: 10.1016/j.vetmic.2010.07.019. PubMed DOI
De Cock AW, Mendoza L, Padhye AA, Ajello L, Kaufman L. Pythium insidiosum sp. nov., the etiologic agent of pythiosis. J. Clin. Microbiol. 1987;25:344–349. doi: 10.1128/JCM.25.2.344-349.1987. PubMed DOI PMC
Mendoza L, Hernandez F, Ajello L. Life cycle of the human and animal oomycete pathogen Pythium insidiosum. J. Clin. Microbiol. 1993;31:2967–2973. doi: 10.1128/JCM.31.11.2967-2973.1993. PubMed DOI PMC
Thianprasit M, Chaiprasert A, Imwidthaya P. Human pythiosis. Curr. Top. Med. Mycol. 1996;7:43–54. PubMed
Mendoza L, Newton JC. Immunology and immunotherapy of the infections caused by Pythium insidiosum. Med. Mycol. 2005;43:477–486. doi: 10.1080/13693780500279882. PubMed DOI
Suthiwong J, Thongsri Y, Yenjai C. A new furanocoumarin from the fruits of Scaevola taccada and antifungal activity against Pythium insidiosum. Nat. Prod. Res. 2017;31:453–459. doi: 10.1080/14786419.2016.1188100. PubMed DOI
Thongsri Y, et al. Detection of diketopiperazine and pyrrolnitrin, compounds with anti-Pythium insidiosum activity, in a Pseudomonas stutzeri environmental strain. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czech Repub. 2014;158:378–383. doi: 10.5507/bp.2012.090. PubMed DOI
Montagner C, et al. Antifungal activity of coumarins. Z. Naturforsch C. J. Biosci. 2008;63:21–28. doi: 10.1515/znc-2008-1-205. PubMed DOI
Ndendoung Tatsimo SJ, Marc Lamshöft J-D-DT, Mouafo FerdinandTalontsi, Lannang AlainMeli, Sarkar Prodipta, Prasanta Kumar Bag MS. LC-MS guided isolation of antibacterial and cytotoxic constituents from Clausena anisata. Medicinal Chem. Res. 2015;24:12.
Leon M, et al. Antifungal activity of selected indigenous pseudomonas and bacillus from the soybean rhizosphere. Int. J. Microbiol. 2009;2009:572049. doi: 10.1155/2009/572049. PubMed DOI PMC
Al-Rubaye AF, Hameed KM. IH. Characterization of antifungal secondary metabolites produced by Klebsiella pneumoniae and screening of its chemical compounds using GC-MS. Int. J. Curr. Pharm. Rev. Res. 2017;8:8. doi: 10.7897/2230-8407.08012. DOI
Tracy LE, Minasian RA, Caterson EJ. Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound. Adv. Wound Care. 2016;5:119–136. doi: 10.1089/wound.2014.0561. PubMed DOI PMC
Dick, M.K., Miao, J.H. & Limaiem, F. in StatPearls (Treasure Island (FL); 2020).
Hilton RE, Tepedino K, Glenn CJ, Merkel KL. Swamp cancer: a case of human pythiosis and review of the literature. Br. J. Dermatol. 2016;175:394–397. doi: 10.1111/bjd.14520. PubMed DOI
De Souza Silveira Valente, J. et al. In vitro anti-Pythium insidiosum activity of biogenic silver nanoparticles. Med Mycol (2018). PubMed
Loreto ES, Tondolo JSM, Santurio JM, Alves SH. Screening of antibacterial drugs for antimicrobial activity against Pythium insidiosum. Med. Mycol. 2019;57:523–525. PubMed
Araujo MJ, Bosco SM, Sforcin JM. Pythium insidiosum: inhibitory effects of propolis and geopropolis on hyphal growth. Braz. J. Microbiol. 2016;47:863–869. doi: 10.1016/j.bjm.2016.06.008. PubMed DOI PMC
De Souza Silveira Valente J, et al. In Vitro Activity of Melaleuca alternifolia (Tea Tree) in Its Free Oil and Nanoemulsion Formulations Against Pythium insidiosum. Mycopathologia. 2016;181:865–869. doi: 10.1007/s11046-016-0051-2. PubMed DOI
De Souza Silveira Valente J, et al. In Vitro Susceptibility of Pythium insidiosum to Melaleuca alternifolia, Mentha piperita and Origanum vulgare Essential Oils Combinations. Mycopathologia. 2016;181:617–622. doi: 10.1007/s11046-016-0019-2. PubMed DOI
Trolezi R, et al. Stryphnodendron adstringens and purified tannin on Pythium insidiosum: in vitro and in vivo studies. Ann. Clin. Microbiol. Antimicrob. 2017;16:7. doi: 10.1186/s12941-017-0183-3. PubMed DOI PMC
Wittayapipath K, et al. Analysis of xanthyletin and secondary metabolites from Pseudomonas stutzeri ST1302 and Klebsiella pneumoniae ST2501 against Pythium insidiosum. BMC Microbiol. 2019;19:78. doi: 10.1186/s12866-019-1452-4. PubMed DOI PMC
Santos JCN, et al. Thimerosal changes protein conformation and increase the rate of fibrillation in physiological conditions: Spectroscopic studies using bovine serum albumin (BSA) Int. J. Biol. Macromol. 2018;113:1032–1040. doi: 10.1016/j.ijbiomac.2018.02.116. PubMed DOI
Geier DA, et al. Thimerosal: clinical, epidemiologic and biochemical studies. Clin. Chim. Acta. 2015;444:212–220. doi: 10.1016/j.cca.2015.02.030. PubMed DOI
Montagner C, et al. In Vitro Cytotoxic Screening of Coumarins. Lat. Am. J. Pharm. 2011;30:1669–1674.
Chaiprasert A, et al. Pythium insidiosum Thai isolates: molecular phylogenetic analysis. Asian Biomed. 2009;3:623–633.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4. PubMed DOI
Riss, T. L. et al. in Assay Guidance Manual. (eds. G.S. Sittampalam et al.) (Bethesda (MD); 2004).